Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer

NCT00191243 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

237

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Gemcitabine
DRUG: docetaxel

Sponsor

Eli Lilly and Company